Pull up any directory of Zirakpur pharma manufacturers and you’ll spot the trick within five entries. Two completely different kinds of company sit on the same list. The first are real plants, licensed under the Punjab Drug Controller, actually making medicine on site. The second are PCD pharma franchise outfits running a wholesale licence and a brand name, but the tablets and syrups they sell get manufactured somewhere else. Sometimes back in the Zirakpur belt at a partner plant. Sometimes in Baddi, sometimes 250 km away in Sonipat, sometimes up in Sikkim. Both kinds tag themselves “pharmaceutical company” on their websites, so the directories just mash them together. If you’re a brand owner shopping for a third party manufacturer to physically produce your product, that mashup is a problem.
So this piece is the manufacturer-focused guide. Only the real plants. The ones holding their own Form 25 or Form 28 manufacturing licence from the Punjab Drug Controller, with verified plant addresses where we have them, and with the regulatory references you’ll want for due diligence before signing anything. The wider Zirakpur PCD franchise cluster (300 to 500-plus brand-owner trading companies packed into a 15 kilometre radius) is a separate phenomenon and a separate sourcing decision altogether. Primary sources we lean on here: the Punjab Department of Health and Family Welfare, which houses the Drug Controller. The CDSCO North Zone Ghaziabad. And the CDSCO approved manufacturing sites by state FDA online portal.
What the data tells you
Some terminology gets mixed up constantly. Worth sorting before going further.
Third party manufacturing. You own the brand. Supply your own formula or pick from the manufacturer’s existing molecule list. They make the medicine, print your brand on the strip, hand you the boxes. You sell it wherever you like.
Loan licence manufacturing. You hold a sales licence and contract a licensed manufacturer’s facility to produce on your behalf. The product is legally manufactured at the loan licence plant. Same building. Different paper trail.
Contract manufacturing. Third party at large B2B scale. Usually Rs. 50 lakh and above per order.
PCD pharma franchise. The mirror image of third party. You take an existing brand from a PCD company, get monopoly territory rights, distribute their brand inside their packaging.
When a Zirakpur company tells you on its website that it “offers pharma manufacturing,” that line can mean two completely different things. They could be doing actual in-house production. Or they’re a brand-owner PCD trading company contracting the real work out to a Baddi or Sonipat plant 60 to 200 kilometres down the road. The way to settle it is to verify the Form 25 manufacturing licence on the CDSCO approved sites by State FDA portal. Or check directly with the Punjab Drug Controller. No licence in their own name, no manufacturer. They’re a brand owner or a distributor.
Why Zirakpur evolved this way
Zirakpur grew up as a PCD-first cluster for a fairly specific reason. Look at the map. The belt sits 15 kilometres from Chandigarh. Mohali is 25 kilometres away. Panchkula about 30. The Baddi BBN industrial belt is 50 kilometres off, just across the Himachal Pradesh state line. For somebody starting a pharma brand in the early 2000s, that geography made the whole thing close to effortless.
- Register a private limited company at a Zirakpur address (cheap real estate, low overheads).
- Source manufacturing from Baddi using loan licence or third party arrangements, roughly a 60 km drive.
- Recruit medical representatives and PCD distributor partners from the wider Chandigarh-Mohali talent pool.
- Ship product nationally through the Chandigarh transport network.
Which is why the Zirakpur “pharma cluster” census usually throws up 300 to 500-plus companies in the immediate area. But the count of actual licensed manufacturers with their own plant? Considerably smaller. Maybe 30 to 60. The rest are PCD brand owners and trading houses contracting their production somewhere else.
For a brand owner picking a Zirakpur partner, the practical question splits two ways. Do you want a PCD brand to white-label? Any of the 300-plus trading companies might fit. Do you want an actual manufacturer producing your formulation on their own licence? Then the shortlist shrinks to that smaller pool, which is what this article covers.
The actual Zirakpur-area manufacturers, by category
Mid-size manufacturers with own plants in the Zirakpur-Mohali belt
Innovexia Life Sciences Private Limited. Office address Pabhat Road, Zirakpur 140603, Mohali district, Punjab. Manufacturing facility at Industrial Build Up Unit No. 1411, Sector 82, JLPL, Mohali 160055, Punjab. Operates both as a pharma franchise giver and a third party manufacturer. Product range covers derma, cardiac, anti-diabetic, paediatric and general allopathic. The Innovexia corporate site walks through the third party manufacturing and pharma franchise services. Manufacturing presence verified via the JLPL Sector 82 Mohali plant. One thing worth noting: the Pabhat Road Zirakpur location reads as the corporate office, while actual production happens at the JLPL Sector 82 facility just over the Punjab-Chandigarh border.
Mediganza Healthcare. SCF 374, Behind Bank of Maharashtra, Zirakpur-Patiala Road, AKS Colony, Bhabat, Zirakpur 140603. Established 2013. Manufactures pharmaceutical tablets and injectables. Particularly known for ophthalmic (eye drops) and veterinary divisions. WHO-GMP and ISO certified. The Mediganza Healthcare IndiaMART profile lists the product range. For third party purposes: if you’re launching an ophthalmic brand or a veterinary line, Mediganza is one of the very few Zirakpur options. Most other Zirakpur-area manufacturers don’t handle ophthalmic formulations because the sterile-manufacturing infrastructure requirement is meaningfully higher.
Tricola Healthcare. Operates from the Zirakpur-Mohali belt. Third party plus PCD franchise. General allopathic range. Verify the manufacturing licence directly with the Punjab Drug Controller before any engagement.
Mediley Healthcare. Zirakpur-area third party and PCD pharma. General allopathic plus a selective specialty range. As with Tricola, verify the Form 25 or 28 manufacturing licence is in their own name and at the claimed plant address before transferring any advance.
Pharma Drugs and Chemicals Unlimited. One of the older Zirakpur names. Plant in Zirakpur. Offers pharmaceutical tablets, capsules, herbal products and syrups. Both third party manufacturing and PCD pharma franchise. For third party: standard 5,000 to 10,000 unit MOQ per SKU. WHO-GMP plus DCGI manufacturing licence currently valid.
Macro Labs Private Limited. ISO-certified PCD pharma company based in Zirakpur. Operates across both PCD franchise and third party manufacturing arrangements. Product range covers general allopathic across multiple therapy segments.
JES Pharmacia. A leading PCD pharma company serving the Indian market for over a decade. WHO-GMP, cGMP and ISO certified. Strong PCD franchise network with third party order capacity. Verify the manufacturing licence and plant location before classifying as an in-house manufacturer rather than a trading-house arrangement.
Arlak Biotech. Zirakpur-based pharmaceutical company with a specialised range that runs from dermatology to cardiac care products. Known for niche therapy depth rather than wide general range. Useful if your brand is in derma, cardiac or related specialty segments.
Homogreen Pharmaceuticals. Zirakpur-based. WHO-GMP certified. Offers tablets, capsules, syrups, injections, ointments and ayurvedic-allopathic blend formulations. That ayurvedic-allopathic line is genuinely uncommon in the Zirakpur cluster, useful if your brand has a parallel ayurvedic range.
Otik Biotec, Janaxa Pharmaceuticals, Bendic Health Care. Mid-tier Zirakpur manufacturers, general allopathic range. Standard 5,000 to 10,000 unit MOQ. Lead time 30 to 45 days first order. Verify each one’s specific manufacturing licence and current plant operational status before engagement.
Smaller and mid-tier units worth a call
Beyond the named manufacturers above, the Zirakpur-Mohali belt has another 20 to 30 licensed pharma manufacturing units of various sizes. Yes Tar Biotech, Sumac Pharma, Innosearch Biotech, Salus Pharma, Glycon Healthcare are some of the additional names that show up in industry directories. The Pharmchoices list of Mohali pharmaceutical companies gives broader coverage. The Pharmchoices Punjab biotech and pharmaceutical companies list is another decent source. Before approaching any specific plant, cross-reference it against the CDSCO approved manufacturing sites by state FDA portal.
What this article deliberately does not cover
The 300-plus PCD pharma franchise trading companies headquartered in Zirakpur, Bhabat, Pabhat Road and the wider Mohali district are a different category and a different sourcing decision. They’re brand owners and distributors, often with their own brand portfolios and territory franchise arrangements, but they typically don’t hold a manufacturing licence of their own. If your plan is to take a PCD franchise from one of those companies and distribute their brand in your territory, that’s an entirely different evaluation from picking a Zirakpur manufacturer to make your own brand. The two roles run on different commercial logic. Different contracts. Different regulatory paperwork.
What makes the Zirakpur manufacturing pool different from Baddi
Three factors.
First, the state regulator is different. Zirakpur-Mohali manufacturers are licensed by the Punjab Department of Health and Family Welfare, not the Himachal Pradesh State Drug Controller. CDSCO federal oversight is the same through the CDSCO North Zone Ghaziabad. But state-level Form 25 and 28 issuance, plant inspections, and licence renewals all route through the Punjab Drug Controller’s office. The procedure differs from Himachal in detail, though both are aligned to the same central Drugs and Cosmetics Rules.
Second, no excise duty tax-incentive heritage. Punjab didn’t get the 2003 Industrial Policy tax holiday that turned Baddi-Barotiwala-Nalagarh into India’s largest pharma formulation cluster. Zirakpur manufacturers built up without that cost tailwind. The economic logic is leaner. Most are organisations that scaled up from PCD trading into manufacturing (often by MR-turned-distributor entrepreneurs), not tax-incentive arbitrage plays.
Third, smaller plant scale on average. Zirakpur plants typically run 5,000 to 30,000 sq ft of manufacturing area. Baddi plants commonly run 15,000 to 80,000 sq ft. The trade-off shows up like this. Zirakpur plants are more accessible to first-time brand owners (smaller sales teams, more personal relationship-style account management) but the product-range diversity per plant tends to be narrower.
For a brand owner placing their first third party order, Zirakpur can be a softer landing than Baddi. Plants are smaller. Sales teams more patient with first-time buyers. The relationship has more handholding built in. For an established brand owner with volume to deploy on larger orders, Baddi will usually offer more cost-competitive options because of scale and concentration.
What to verify before signing a Zirakpur manufacturer
A practical due-diligence checklist, drawn from working with brand owners in the Chandigarh-Mohali-Zirakpur corridor.
Verify the Punjab Drug Controller manufacturing licence. This is the single most important check, particularly given that PCD trading vs in-house manufacturing distinction. Ask the company for a copy of the Form 25 (allopathic) or Form 28 (restricted) manufacturing licence. The licence will sit in the company’s own name and will specify the plant address. Cross-check on the CDSCO approved manufacturing sites by state FDA portal. If the company offers you a manufacturing arrangement but can’t produce a Form 25 or 28 in their own name at the claimed plant address, you’re not dealing with a manufacturer. You’re dealing with a PCD brand owner or a trading house contracting the work out.
Verify Revised Schedule M compliance. Effective 1 January 2026, binding for every Indian drug manufacturer per the CDSCO 10 November 2025 directive. Reference: CDSCO Schedule M guidelines PDF. Smaller Zirakpur plants face proportionally higher compliance cost relative to revenue, so Schedule M evidence is especially worth verifying.
Verify the WHO-GMP certificate where claimed. Cross-check on the CDSCO WHO-GMP certified manufacturers list PDF.
Visit the plant. Drive to Zirakpur from Chandigarh. About 15 kilometres on the Chandigarh-Patiala road. Walk in, see the place yourself. Ask for a plant tour. A genuine manufacturer will host you. A PCD trading company without a real plant will hedge with vague excuses, redirect you to their “partner plant” elsewhere, or offer to show you only the office. This single step is the most reliable filter against PCD-trader-pretending-to-be-manufacturer arrangements.
Get an NDA on your formula. If you’re supplying a proprietary formula, get a non-disclosure agreement in place before sharing details.
Ask for a 50 to 100 strip first-batch verification sample. Send 2 to 3 strips to an NABL-accredited third party testing laboratory for active content, dissolution, and impurity profile testing.
File your trademark before placing the order. The Trade Marks Registry application acknowledgement should be filed before packaging plates are made.
Start small. 5 to 10 SKUs of fast-moving products. Learn the manufacturer’s responsiveness before scaling up.
Lock pricing transparency. Per-unit breakdown covering API, excipients, packaging, manufacturing overhead, taxes, and margin.
Lead time commitment in writing. Standard 30 to 45 days for first order, 25 to 35 days for repeat.
Documents you need before approaching any manufacturer
- Drug licence Form 20B (retail) and 21B (wholesale) issued by your state Drug Controller
- GST registration certificate
- Aadhaar and PAN of proprietor or authorised signatory
- Cancelled cheque of the firm’s current account
- Firm letterhead with trade name
- Brand trademark application acknowledgement or registration certificate
- Some manufacturers will also ask for the last 6 months bank statement
The Drug Licence in Punjab compliance guide covers the procedural framework for your own state Drug Controller filings. Punjab manufacturing licence renewal itself is handled through the renew drug manufacturing licences in Punjab portal.
A short word about Zirakpur as a third party hub
Zirakpur sits in Mohali district, Punjab. Roughly 15 kilometres south of Chandigarh on the Chandigarh-Patiala road, with Mohali, Panchkula and the wider Chandigarh metropolitan area inside a 20-kilometre arc, and Baddi about 50 kilometres away by road.
The actual licensed Zirakpur pharma manufacturing pool runs 30 to 60 units depending on how you count the borderline cases. The wider Zirakpur PCD trading cluster (a separate category) is the 300 to 500-plus brand owner trading companies, many of whom are office-only registrations contracting their production to Baddi or Sonipat. The combined density makes Zirakpur the most concentrated pharma commercial node per square kilometre in India by some measures.
Operating costs in Zirakpur sit a bit lower than central Chandigarh but higher than rural Himachal areas like Baddi-Nalagarh. The trade-off you get for those costs is better access to skilled pharma workforce, banking and logistics infrastructure, and faster connections to and from Chandigarh airport.
The CDSCO North Zone jurisdiction
Zirakpur and Mohali manufacturers fall under the CDSCO North Zone Ghaziabad federal jurisdiction (Punjab, Haryana, HP, Uttarakhand, Delhi, UP, J&K, Ladakh, Chandigarh). Federal inspections, WHO-GMP audits and central drug safety alerts all flow through Ghaziabad. State Form 25 and 28 issuance, plant inspections and renewals stay with the Punjab Drug Controller.
DPCO 2025 and pricing context
The NPPA DPCO 2025 16 percent combined retail-distributor margin cap on 743 scheduled formulations affects what PCD distributors and chemists earn on cardiac, anti-diabetic, basic antibiotics, and chronic care SKUs, regardless of which Indian manufacturer makes them. Brand owners using Zirakpur manufacturers for non-DPCO specialty molecules (SGLT2 inhibitors, DPP-4 newer formulations, ARNI, cosmeto-pharma, premium nutraceuticals) preserve better margin headroom.
Common questions
What is the minimum investment to start a brand via Zirakpur third party manufacturing? Realistically, Rs. 2 to Rs. 5 lakh for a first order at 5 to 10 SKUs of 5,000 units each. Plus packaging plate charges (Rs. 2,000 to Rs. 5,000 per SKU, one-time), trademark registration, storage and distribution setup. Total starter budget Rs. 5 to Rs. 10 lakh.
Are Zirakpur manufacturers cheaper or more expensive than Baddi? Roughly similar on per-unit pricing. Sometimes a touch higher in Zirakpur thanks to Punjab labour costs, sometimes lower for specific therapy segments. Decide on fit and quality first. Price second.
Do Zirakpur manufacturers ship pan-India? Yes. Standard transit 1 to 2 days to Delhi NCR, 2 to 3 days to Mumbai, 3 to 4 days to Bangalore and Kolkata, 4 to 5 days to Chennai.
Will the manufacturer take my own brand and formula? Most genuine Zirakpur manufacturers will. The PCD trading companies in the wider Zirakpur cluster will also offer to take your order, but the actual manufacturing happens at a contract plant elsewhere. Distinguish the two before signing.
Do they take expiry stock back? Mostly no. Plan first order size carefully.
Are there Zirakpur PCD franchise opportunities for distributors? Yes, extensively. Most Zirakpur companies offer PCD pharma franchise with monopoly territory rights. If your goal is to take an existing brand and distribute in your district or state, that’s a separate arrangement from third party manufacturing. Ask the company specifically about PCD franchise terms.
WHO-GMP enough, or do I need more? WHO-GMP plus DCGI manufacturing licence plus ISO 9001 is the standard combination for domestic third party. For export, additional certifications (USFDA, MHRA, EU GMP, TGA) are required.
How do I verify a Zirakpur manufacturer before sending an advance? Five checks. Visit the plant. Verify the Punjab Drug Controller Form 25 or 28 licence in the company’s own name. Verify Revised Schedule M compliance evidence. Call 2 to 3 existing third party clients. Cross-check on Google reviews and the CDSCO approved manufacturing sites portal. Do at least 3 of these before transferring any advance above Rs. 50,000.
How do I tell a Zirakpur manufacturer from a Zirakpur PCD trading company? Ask for the Form 25 or 28 manufacturing licence in their own name at the claimed plant address. Verify on cdscoonline.gov.in/CDSCO/manuf_site. Then visit the plant and physically see manufacturing happening. If either step fails, you’re dealing with a PCD trading house, not a manufacturer.
Sources and references
State regulatory
- Punjab Department of Health and Family Welfare (houses the Drug Controller)
- Renew Drug Manufacturing Licences in Punjab
- PSR Compliance – Drug Licence in Punjab guide
- Punjab State Pharmacy Council
Central regulatory
- Central Drugs Standard Control Organisation (CDSCO)
- CDSCO North Zone Ghaziabad
- CDSCO Approved Manufacturing Sites by State FDA portal
- CDSCO WHO-GMP certified manufacturers list PDF
- CDSCO Revised Schedule M guidelines PDF
- CDSCO Drugs and Cosmetics Rules
- BusinessToday – CDSCO comply by January 1 directive November 2025
Central pricing and policy
- National Pharmaceutical Pricing Authority (NPPA)
- Trade Marks Registry, Government of India
- NABL India – accredited testing laboratories
Company verified information
- Innovexia Life Sciences corporate site
- Innovexia Life Sciences pharma franchise and third party manufacturing page
- Innovexia Life Sciences on PharmaKhabar
- Innovexia Life Sciences IndiaMART profile
- Mediganza Healthcare IndiaMART
Industry directories and references
- Pharmchoices – list of pharmaceutical companies in Mohali
- Pharmchoices – biotech and pharmaceutical companies in Punjab
- Monopoly PCD Punjab industry directory
- Taksapharma – top pharma manufacturing companies in Punjab
- BioPharLifeSciences – top pharmaceutical companies in Chandigarh
Industry data
Some points on this guide
Plant level production data isn’t publicly disclosed for most mid-sized Indian pharma manufacturers, and that includes most Zirakpur-area units. Manufacturing capacity, MOQ flexibility, and current operational status are best verified through a direct conversation with the manufacturer plus a physical plant visit.
Founding years and product range data come from publicly available company information and industry directory listings. Always verify directly with the manufacturer before signing a purchase order or supply agreement.
The Zirakpur-Mohali-Panchkula tri-city geographic area is administratively split between Punjab (Zirakpur, Mohali) and Haryana (Panchkula) state lines, with the union territory of Chandigarh sitting between them. Some companies cite tri-city addresses across this border. This article has covered companies with primary operations on the Punjab side, in Zirakpur, Mohali district, or the immediately adjoining Pabhat-Bhabat-JLPL Sector 82 cluster.
Regulatory references (Revised Schedule M, DPCO 2025, CDSCO directives) are current as of early 2026, based on the latest available central and state regulatory notifications.
The distinction between in-house licensed manufacturers and PCD pharma franchise trading companies is the most important verification step in the Zirakpur cluster. More so than in any other Indian pharma geography. Brand owners who skip the Form 25/28 verification and rely on website claims regularly end up with arrangements where their product is actually being made 60 to 200 kilometres away, with different quality controls than they thought they were getting. Verify the manufacturing licence. Visit the plant. Do both before transferring any advance.
If you’ve personally worked with a Zirakpur third party manufacturer that we’ve missed or that warrants additional detail, please get in touch. We update this article every 2 to 3 months based on what brand owners on the ground are actually using.
You might also like
Hair Fall After 30 in Indian Women: Why “All Reports Normal” Is Almost Always Wrong
Most Indian women over 30 are told their hair fall reports are 'normal.' They're not — they're being…
Read article →
Top 50 Pharmaceutical Companies in India 2026: Verified Revenue, Market Cap, and Third Party Access
Most "Top 50 Pharma Companies in India" lists are copies of copies. Here every name is checked against…
Read article →
Top Third Party Pharma Manufacturers in Baddi (For Your Own Brand, 2026)
Twenty-three Baddi third party pharma manufacturers ranked for brand owners — MOQ, lead times, therapy strengths, and what…
Read article →